Daniel Adunkwah: Reimagining Safety and Choice with Autologous Blood Transfusions
Daniel Adunkwah, Doctor of Medical Laboratory Science, Laboratory Manager at Presbyterian Health Services, shared a post on LinkedIn:
“Autologous Blood Transfusion: A Significant Moment in Patient Care and Choice
Recent developments within the community of Jehovah’s Witnesses have brought renewed attention to an important medical practice, autologous blood transfusion. With increasing openness toward members receiving their own blood, this approach is becoming even more relevant in clinical care and patient centered medicine.
Autologous blood transfusion involves collecting and reinfusing a patient’s own blood, either before surgery or during a medical procedure. It is a concept that continues to bridge medical innovation with individual beliefs and healthcare preferences.
1. Why this matters now
Autologous transfusion provides an option that aligns medical treatment with personal convictions. For many patients, especially those who have previously declined donor blood, this development offers a pathway to safer surgical care while respecting deeply held beliefs.
2. Clinical significance
From a clinical perspective, autologous blood transfusion reduces the risk of transfusion transmitted infections and eliminates compatibility concerns. It is particularly useful in surgeries where significant blood loss is expected, and it supports modern strategies in patient blood management.
3. The broader healthcare insight
This moment highlights something important in medicine, the need to continually adapt care to meet patients where they are. When clinical science and patient values work together, outcomes improve and trust in healthcare grows stronger.
Autologous blood transfusion reminds us that sometimes the safest and most acceptable solution is one that comes directly from the patient themselves.
Dr. Daniel Adunkwah
Doctor of Medical Laboratory Science”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy